
Māori Almost Twice As Likely To Die After Bowel Cancer Surgery
Confronting research data reveals Māori almost twice as likely to die after bowel cancer surgery
Māori are almost twice as likely as Pākehā to die from complications following bowel cancer surgery, new research shows.
The study, just published in the British Journal of Surgery, found that Māori patients having bowel or gut cancer surgery were slightly more likely to experience complications, such as infections, bleeding, or organ failure.
However, the more concerning finding was that Māori were significantly less likely than Pākehā patients to survive those complications.
'That tells us something is going wrong with how our hospital systems respond to Māori patients with problems after surgery,' says lead author Dr Cameron Wells, a doctoral candidate in surgery at Waipapa Taumata Rau, University of Auckland.
'It's not just whether complications happen, but how quickly and effectively they're picked up and treated. Our study shows that for Māori patients, those crucial steps often come too late,' says Wells.
The research team included Māori and Pākehā doctors from several hospitals and the universities of Otago and Auckland. They analysed hospital records and data from the New Zealand Cancer Registry for more than 31,000 patients between 2005 and 2020.
During this period, hospital teams improved at identifying and treating complications in Pākehā patients, with deaths approximately halving. However, survival rates for Māori showed negligible improvement, widening the mortality gap over the 16 years.
'This is very concerning and confronting data,' says Wells.
The study points to structural racism in the healthcare system, unconscious bias, and poor communication as key contributors to the disparity. It highlights that Māori patients with early symptoms of complications may be taken less seriously, causing harmful delays in diagnosis and treatment.
Dr Jonathan Koea (Ngāti Mutunga, Ngāti Tama), a professor of surgery in the Faculty of Medical and Health Sciences at Waipapa Taumata Rau, University of Auckland, says this study builds on earlier research.
A 2023 paper, also led by Wells, found Māori are proportionally more likely to be treated at hospitals with higher rates of post-surgical deaths. These hospitals often have fewer resources to recognise and respond to complications after surgery. (See Annals of Surgery ' Failure to rescue following colorectal cancer resection'.)
Koea also referenced earlier research he was involved with, led by University of Otago Māori epidemiologist Professor Jason Gurney, which found Māori were more likely to die after elective surgery than Pākehā. Contributing factors included communication issues and assumptions about health literacy. (See NZMJ 17 September 2021.)
'This latest study is complex, because it's about something that doesn't happen, a patient's life is not saved when they experience a complication, which makes it hard to measure,' Koea says.
'The research sits within the broader context of the Māori patient journey with cancer. From the outset, Māori are less likely to be screened, less likely to have a GP, more likely to require emergency surgery, and less likely to be referred to an oncologist.
'It's a pattern of multiple slippage points, which is why Māori are more likely to die six or seven years earlier than Pākehā,' Koea says. 'Māori are more likely to experience complications and less likely to be rescued. It aligns with what we already know.
'It shows that treating everyone equally results in unequal outcomes – you have to treat Māori differently to achieve the same outcomes.'
Recommendations for improvements
The paper recommends identifying and removing barriers to equitable care by embedding cultural safety and anti-racism training for all clinical staff to improve post-surgical outcomes.
Strengthening Māori-led models of care and incorporating whānau perspectives into surgical pathways may also improve trust, responsiveness, and outcomes.
Wells says the next step is to move from research describing inequities to actually doing something about them.
'We already know where many of the problems lie – the focus now must be on partnering with Māori communities to co-design solutions. That means listening, acting, and making sure the health system delivers care that is culturally safe, equitable, and accountable,' Wells says.
There are a range of initiatives under way across New Zealand, he adds.
'One initiative I think has potential is called Kōrero Mai, which enables patients and their families to speak up and request a review by more senior staff in hospital when they are worried about something going wrong.
'We know that for Māori patients, there are significant cultural barriers – this is a broader issue, not limited to surgery.'
While hospitals are taking steps to improve monitoring and treatment after surgery, this research suggests current efforts are benefiting some patients but not others.
'We need to be very careful about what we do next, because the gap is getting wider.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scoop
an hour ago
- Scoop
New Project Tackles Breast Cancer Inequity
Press Release – University of Auckland The five-year project will offer a new model of care designed to overcome inequities faced by Mori women with breast cancer, says Laking. A major new project focused on Māori women with breast cancer is launching, with a $5 million grant from the Health Research Council. University of Auckland Associate Professor George Laking from Te Aka Mātauranga Matepukupuku, Centre for Cancer Research is leading the Whiria te Aka Matua project, with Dr Nina Scott from Te Whatu Ora, Health New Zealand. The five-year project will offer a new model of care designed to overcome inequities faced by Māori women with breast cancer, says Laking. Wāhine Māori have a 46 percent higher incidence of breast cancer than European New Zealanders, he says. When breast cancer is picked up by screening, Māori women have the same chance of survival as other New Zealanders. However, about 45 percent of all wāhine Māori who have breast cancer are diagnosed outside of screening programmes, after they notice symptoms, such as a lump. Māori women with symptomatic breast cancer have a 37 percent lower rate of survival than European New Zealanders, he says. 'The reasons for this are many, but one of the things we urgently need to improve is the design of the health system. 'We hope the model of care we are developing will turn the inequity around, so there's no longer a survival disadvantage for Māori women with symptomatic breast cancer,' says Laking. The research team includes experts from Waipapa Taumata Rau, University of Otago, and Waikato and Auckland hospitals. They aim to enrol 160 Māori women with suspected breast cancer into their study. The women who are diagnosed with breast cancer will receive wrap-around care for themselves and their whānau. Three interventions will be offered, starting with the whiri model of care. This involves a health navigator ensuring the whānau know what is happening, what health services are needed and how to get to appointments. The health navigator will assess the health of the whole family. 'We want to implement a family model of care, in contrast to prevalent models that are centred on individual patients. 'Major health issues have flow-on effects through families. Sometimes one person is diagnosed with cancer and a family member worries themselves sick. 'We want to make sure the health of all people in the family is on track, at a time when they need it,' says Laking. The next intervention will be Whānau Hauora Portfolios. These will provide a core plan of care, which can be easily updated and communicated with different teams. They will also be a place where whānau can record what happens on the cancer journey. The third intervention will be prehabilitation, a holistic programme designed to prepare women for the stress of treatments, such as surgery, radiation and chemotherapy. Prehabilitation – occuring between diagnosis and when treatment begins – could include support with exercise, nutrition, psychological and social needs, and rongoā Māori. 'It will help make sure women are as well as possible at the beginning of their cancer treatment. 'In European populations with cancer, prehabilitation has been shown to shorten the average length of hospital stay and to reduce post-surgical complications,' says Laking. Two evaluations will be offered – the first, assessing signs of inflammation in the women's blood samples, to see how these are affected by prehabiltation and cancer treatments. A holistic evaluation of the value of the entire programme will also be presented. The kete of resources will be co-designed with wāhine Māori with breast cancer, through interviews and focus groups. Several wānanga will be held to collaborate with the wider health community on the programme. Laking says what works for Māori women will have benefits for many patient communities. 'We're focusing our research on Māori women, because that's the area of greatest immediate need, but the model of care we're developing will be useful for all New Zealand women with breast cancer. 'This model could be relevant for a wide range of conditions, not just in Aotearoa, but globally,' says Laking.


Scoop
an hour ago
- Scoop
New Project Tackles Breast Cancer Inequity
Press Release – University of Auckland The five-year project will offer a new model of care designed to overcome inequities faced by Mori women with breast cancer, says Laking. A major new project focused on Māori women with breast cancer is launching, with a $5 million grant from the Health Research Council. University of Auckland Associate Professor George Laking from Te Aka Mātauranga Matepukupuku, Centre for Cancer Research is leading the Whiria te Aka Matua project, with Dr Nina Scott from Te Whatu Ora, Health New Zealand. The five-year project will offer a new model of care designed to overcome inequities faced by Māori women with breast cancer, says Laking. Wāhine Māori have a 46 percent higher incidence of breast cancer than European New Zealanders, he says. When breast cancer is picked up by screening, Māori women have the same chance of survival as other New Zealanders. However, about 45 percent of all wāhine Māori who have breast cancer are diagnosed outside of screening programmes, after they notice symptoms, such as a lump. Māori women with symptomatic breast cancer have a 37 percent lower rate of survival than European New Zealanders, he says. 'The reasons for this are many, but one of the things we urgently need to improve is the design of the health system. 'We hope the model of care we are developing will turn the inequity around, so there's no longer a survival disadvantage for Māori women with symptomatic breast cancer,' says Laking. The research team includes experts from Waipapa Taumata Rau, University of Otago, and Waikato and Auckland hospitals. They aim to enrol 160 Māori women with suspected breast cancer into their study. The women who are diagnosed with breast cancer will receive wrap-around care for themselves and their whānau. Three interventions will be offered, starting with the whiri model of care. This involves a health navigator ensuring the whānau know what is happening, what health services are needed and how to get to appointments. The health navigator will assess the health of the whole family. 'We want to implement a family model of care, in contrast to prevalent models that are centred on individual patients. 'Major health issues have flow-on effects through families. Sometimes one person is diagnosed with cancer and a family member worries themselves sick. 'We want to make sure the health of all people in the family is on track, at a time when they need it,' says Laking. The next intervention will be Whānau Hauora Portfolios. These will provide a core plan of care, which can be easily updated and communicated with different teams. They will also be a place where whānau can record what happens on the cancer journey. The third intervention will be prehabilitation, a holistic programme designed to prepare women for the stress of treatments, such as surgery, radiation and chemotherapy. Prehabilitation – occuring between diagnosis and when treatment begins – could include support with exercise, nutrition, psychological and social needs, and rongoā Māori. 'It will help make sure women are as well as possible at the beginning of their cancer treatment. 'In European populations with cancer, prehabilitation has been shown to shorten the average length of hospital stay and to reduce post-surgical complications,' says Laking. Two evaluations will be offered – the first, assessing signs of inflammation in the women's blood samples, to see how these are affected by prehabiltation and cancer treatments. A holistic evaluation of the value of the entire programme will also be presented. The kete of resources will be co-designed with wāhine Māori with breast cancer, through interviews and focus groups. Several wānanga will be held to collaborate with the wider health community on the programme. Laking says what works for Māori women will have benefits for many patient communities. 'We're focusing our research on Māori women, because that's the area of greatest immediate need, but the model of care we're developing will be useful for all New Zealand women with breast cancer. 'This model could be relevant for a wide range of conditions, not just in Aotearoa, but globally,' says Laking.


Scoop
2 hours ago
- Scoop
New Project Tackles Breast Cancer Inequity
A major new project focused on Māori women with breast cancer is launching, with a $5 million grant from the Health Research Council. University of Auckland Associate Professor George Laking from Te Aka Mātauranga Matepukupuku, Centre for Cancer Research is leading the Whiria te Aka Matua project, with Dr Nina Scott from Te Whatu Ora, Health New Zealand. The five-year project will offer a new model of care designed to overcome inequities faced by Māori women with breast cancer, says Laking. Wāhine Māori have a 46 percent higher incidence of breast cancer than European New Zealanders, he says. When breast cancer is picked up by screening, Māori women have the same chance of survival as other New Zealanders. However, about 45 percent of all wāhine Māori who have breast cancer are diagnosed outside of screening programmes, after they notice symptoms, such as a lump. Māori women with symptomatic breast cancer have a 37 percent lower rate of survival than European New Zealanders, he says. 'The reasons for this are many, but one of the things we urgently need to improve is the design of the health system. 'We hope the model of care we are developing will turn the inequity around, so there's no longer a survival disadvantage for Māori women with symptomatic breast cancer,' says Laking. The research team includes experts from Waipapa Taumata Rau, University of Otago, and Waikato and Auckland hospitals. They aim to enrol 160 Māori women with suspected breast cancer into their study. The women who are diagnosed with breast cancer will receive wrap-around care for themselves and their whānau. Three interventions will be offered, starting with the whiri model of care. This involves a health navigator ensuring the whānau know what is happening, what health services are needed and how to get to appointments. The health navigator will assess the health of the whole family. 'We want to implement a family model of care, in contrast to prevalent models that are centred on individual patients. 'Major health issues have flow-on effects through families. Sometimes one person is diagnosed with cancer and a family member worries themselves sick. 'We want to make sure the health of all people in the family is on track, at a time when they need it,' says Laking. The next intervention will be Whānau Hauora Portfolios. These will provide a core plan of care, which can be easily updated and communicated with different teams. They will also be a place where whānau can record what happens on the cancer journey. The third intervention will be prehabilitation, a holistic programme designed to prepare women for the stress of treatments, such as surgery, radiation and chemotherapy. Prehabilitation - occuring between diagnosis and when treatment begins - could include support with exercise, nutrition, psychological and social needs, and rongoā Māori. 'It will help make sure women are as well as possible at the beginning of their cancer treatment. 'In European populations with cancer, prehabilitation has been shown to shorten the average length of hospital stay and to reduce post-surgical complications,' says Laking. Two evaluations will be offered – the first, assessing signs of inflammation in the women's blood samples, to see how these are affected by prehabiltation and cancer treatments. A holistic evaluation of the value of the entire programme will also be presented. The kete of resources will be co-designed with wāhine Māori with breast cancer, through interviews and focus groups. Several wānanga will be held to collaborate with the wider health community on the programme. Laking says what works for Māori women will have benefits for many patient communities. 'We're focusing our research on Māori women, because that's the area of greatest immediate need, but the model of care we're developing will be useful for all New Zealand women with breast cancer. 'This model could be relevant for a wide range of conditions, not just in Aotearoa, but globally,' says Laking.